Ultimovacs ASA (ULTI.OL)
NOK 2.76
(14.79%)
NOK 2.76
(14.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -176.14 Million | -167.69 Million | -125.82 Million | -108.22 Million | -62.98 Million | -50.38 Million |
| Net Income | -189.23 Million | -167.79 Million | -164.72 Million | -120.55 Million | -61.16 Million | -55.28 Million |
| Depreciation & Amortization | 2.76 Million | 2.64 Million | 2.7 Million | 2.72 Million | 2.06 Million | 601 Thousand |
| Deferred income taxes | -10.9 Million | -7.17 Million | 3.61 Million | 746 Thousand | 223 Thousand | - |
| Stock-based compensation | 14.25 Million | 20.39 Million | 11.59 Million | 6.77 Million | 1.98 Million | - |
| Change in working capital | 8.88 Million | -6.98 Million | 23.86 Million | 6.39 Million | -1.86 Million | 5.52 Million |
| Other non-cash items | -1.91 Million | -8.78 Million | -2.88 Million | -4.3 Million | -4.23 Million | -1.23 Million |
| Investing Cash Flow | -25 Thousand | 8.69 Million | 2.97 Million | -736 Thousand | 4.31 Million | -3.85 Million |
| Investments in PPE | -25 Thousand | -195 Thousand | -85 Thousand | -5.28 Million | -172 Thousand | -513 Thousand |
| Acquisitions | - | - | - | - | - | -4.58 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 14.05 Million | 8.88 Million | 3.06 Million | 4.54 Million | 4.49 Million | 1.24 Million |
| Financing Cash Flow | -1.46 Million | 3.57 Million | 259.95 Million | 151.01 Million | 343 Million | - |
| Debt repayment | -1767.00 | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 300 Thousand | 5.48 Million | 272.86 Million | 160 Million | 370 Million | - |
| Other Financing Activities | -1.76 Million | -1.9 Million | -12.9 Million | -8.98 Million | -26.99 Million | - |
| Accounts receivables | 3.62 Million | -1.85 Million | 351 Thousand | -433 Thousand | -1.82 Million | -1.1 Million |
| Accounts payables | 5.25 Million | -5.12 Million | 23.5 Million | 6.82 Million | -42 Thousand | 6.63 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 8.88 Million | - | - | - | - | - |
| Cash at beginning of period | 425.3 Million | 574.16 Million | 440.92 Million | 399.6 Million | 115.54 Million | 169.8 Million |
| Cash at end of period | 266.55 Million | 425.3 Million | 574.16 Million | 440.92 Million | 399.6 Million | 115.54 Million |
| Capital Expenditure | -25 Thousand | -195 Thousand | -85 Thousand | -5.28 Million | -172 Thousand | -513 Thousand |
| Effect of forex changes on cash | 18.88 Million | -6.56 Million | -3.86 Million | -739 Thousand | -265 Thousand | -28 Thousand |
| Net cash flow / Change in cash | -158.75 Million | -148.85 Million | 133.24 Million | 41.31 Million | 284.06 Million | -54.26 Million |
| Free Cash Flow | -176.17 Million | -167.89 Million | -125.91 Million | -113.5 Million | -63.16 Million | -50.9 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.76 Million | -22.75 Million | -55.93 Million | -189.23 Million | -55.82 Million | -44.29 Million |
| Depreciation & Amortization | 713 Thousand | 715 Thousand | 686 Thousand | 2.76 Million | 691 Thousand | 691 Thousand |
| Deferred income taxes | - | - | 8.81 Million | -10.9 Million | 4.73 Million | -3.93 Million |
| Stock-based compensation | 3.46 Million | 3.13 Million | 3.17 Million | 14.25 Million | 3.17 Million | 3.7 Million |
| Change in working capital | -9.34 Million | -21.34 Million | 13.35 Million | 8.88 Million | 10.1 Million | -23.83 Million |
| Other non-cash items | 15.55 Million | 22.98 Million | -8.86 Million | -1.91 Million | -3.61 Million | -3.32 Million |
| Investing Cash Flow | 1.94 Million | -17 Thousand | 3.72 Million | -25 Thousand | 3.69 Million | 3.42 Million |
| Investments in PPE | - | -17 Thousand | - | -25 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1941.00 | - | - | - | - | - |
| Financing Cash Flow | -568 Thousand | -476 Thousand | -156 Thousand | -1.46 Million | -537 Thousand | -537 Thousand |
| Debt repayment | -567.00 | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 300 Thousand | 300 Thousand | - | - |
| Other Financing Activities | -70.00 | - | -456 Thousand | -1.76 Million | -537 Thousand | - |
| Accounts receivables | 3.07 Million | -5.24 Million | 8.22 Million | 3.62 Million | 2.59 Million | -5.04 Million |
| Accounts payables | -12.41 Million | -16.09 Million | 5.13 Million | 5.25 Million | 7.5 Million | -18.78 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3073.00 | - | - | - | - | -1000.00 |
| Cash at beginning of period | 219.96 Million | 266.55 Million | 300.27 Million | 425.3 Million | 344.1 Million | 405.52 Million |
| Cash at end of period | 170.4 Million | 219.96 Million | 266.55 Million | 266.55 Million | 300.27 Million | 344.1 Million |
| Capital Expenditure | - | -17 Thousand | - | -25 Thousand | - | - |
| Effect of forex changes on cash | -378 Thousand | -2.93 Million | 5.2 Million | 18.88 Million | -6.24 Million | 6.67 Million |
| Net cash flow / Change in cash | -49.55 Million | -46.59 Million | -33.71 Million | -158.75 Million | -43.83 Million | -61.42 Million |
| Free Cash Flow | -48.61 Million | -43.18 Million | -38.76 Million | -176.17 Million | -40.74 Million | -70.99 Million |
HRSEF
336570
LOKESHMACH
VOD
MLBON
0873